A scoping review of adverse visual outcomes among preterm infants without, versus those with, retinopathy of

Jacqueline R Porteny1, Paige Scudder1, Brian A Darlow2

  • 1Tufts University School of Medicine, Boston, USA.

Survey of Ophthalmology
|November 13, 2025
PubMed

Insights

Retinopathy of prematurity (ROP) increases adverse visual outcomes (AVOs) in preterm infants. However, preterm infants without ROP also experience AVOs, necessitating further research into contributing factors.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Pediatric Medicine

Background:

  • Adverse visual outcomes (AVOs) are prevalent in preterm infants.
  • Retinopathy of prematurity (ROP) is a known risk factor for AVOs.
  • Limited data exists on AVOs in preterm infants without ROP.

Purpose of the Study:

  • To review and synthesize available literature on AVOs in preterm infants.
  • To differentiate AVOs in preterm infants with and without ROP.
  • To identify specific visual impairments associated with ROP and those occurring independently.

Main Methods:

  • Systematic literature search of MEDLINE (PubMed) and Scopus (Elsevier) databases (2007-2023).
  • Keywords included ROP and adverse visual outcomes.
  • Rayyan software used for title/abstract and full-text screening.

Main Results:

  • ROP is linked to higher risks of low vision, blindness, amblyopia, and strabismus.
  • Astigmatism and color vision abnormalities showed weaker associations with ROP.
  • Preterm infants without ROP also experience AVOs, but at lower frequencies.

Conclusions:

  • ROP is a significant risk factor for certain AVOs in preterm infants.
  • Not all AVOs in this population are attributable to ROP.
  • Further investigation is needed to understand the causes of AVOs in preterm infants without ROP.